Adesante funding round gains super interest from investors, marked 140%, and closed in only 3 months
November 09, 2018
Adesante is a company with a brilliant goal and a commendable vision. Their goal is to increase the safety of surgery and their vision: Zero failures in Surgery. Adesante’s top-of-the-line product SurgeryVision™ gained significant investor interest and their funding round closed with 485,000 euros in only three month’s time.
Adesante is a company on a mission. SurgeryVision™, the flagship product of the Finnish health technology company, is a software solution that allows surgeons to plan a surgery in a virtual environment. Their stereoscopic 3D view allows surgeons to plan even the most demanding procedures in advance. SurgeryVision™ helps to improve the surgical process and to decrease the risk of surgical.
The company pitched at FiBAN PitchFinland in April, with the intent of raising 350,000 euros. Their pitch caught the eye of several experienced business angels, resulting in the round closing with 485,000 euros. The round included angels such as Leena Niemistö and Superhero Capital.
With the raised funds, Adesante will aim for rapid internationalization as SurgeryVision™ is one of the top products of Finnish health technology. It has already received excellent feedback from top surgeons and international partners.
Congratulations on closing your round and best of luck with conquering the world!
Read more about the future of high class virtual reality medical devices for healthcare here and here.
More Information:
Petteri Joenpolvi, Chief Executive Officer, Adesante
petteri.joenpolvi@adesante.com
Amel Gaily, FiBAN’s Managing Director
amel@fiban.org
